Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 placebo-controlled trial of upadacitinib in severe alopecia areata
MOH_2023-11-09_012971Phase 3Active, not recruiting
- Sponsor
- AbbVie Inc.
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of upadacitinib in alopecia areata (3 arms), sponsored by AbbVie Inc. Started Oct 2023; status: active, not recruiting.
02
Drugs
upadacitinib
03
Conditions
alopecia areata
Beyond the preview
Go deeper on MOH_2023-11-09_012971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2023-11-09_012971.